TAC T-cells for the Treatment of HER2-positive Solid Tumors

Clinical trial NCT04727151 · TERMINATED

Trial details

NCT number: NCT04727151
Sponsor: Triumvira Immunologics, Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HER2 Positive Gastric Cancer Metastatic HER2 Positive Gastroesophageal Junction Cancer

Start date: 2021-04-19
Primary completion: 2023-12-17
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.